ReviewDementia and neurocognitive disorders2025
Social Cognition in Neurodegenerative Disorders.
Review in Dementia and neurocognitive disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neurodegeneration and Homelessness: A Bidirectional Relationship Shaping Health and Vulnerability.The Yale journal of biology and medicine · 2026Review
- Baseline facial emotion recognition is associated with clinical decline across the Alzheimer's disease spectrum: a multi-instrument longitudinal assessment study.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Social cognition, including theory of mind, empathy, social perception, and behavior, is crucial for interpersonal relationships and social functioning. Impairments in social cognition have also been recognized in neurodegenerative disorders including frontotemporal dementia, Alzheimer's disease, and Parkinson's disease. This review defines social cognition components, summarizes assessment tools, and evaluates their clinical applicability in these disorders. Despite research, the incorporation of social cognition assessments into clinical practice remains limited. Developing standardized, validated tools and integrating them with current, conventional neuropsychological assessments is crucial for improving the diagnosis, prognosis, and management of neurodegenerative disorders. Emerging interventions targeting specific social cognitive domains or their neural systems hold promise in enhancing the social functioning and quality of life of affected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.